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Abstract
Periodontal disease has been shown to be associated with incident stroke. We investigated whether 
periodontal disease is independently associated with recurrent vascular events and certain 
inflammatory markers in stroke/TIA patients. In this prospective longitudinal hospital-based 
cohort study, periodontal disease was assessed in stroke/TIA patients. High periodontal disease 
was defined as the highest tertile of extent (% of sites) with attachment loss ≥ 5 mm. Serum 
interleukin-6, high sensitivity C-reactive protein and soluble intracellular adhesion molecule-1 
were measured. The patients were followed for recurrent vascular events-stroke, TIA, myocardial 
infarction and vascular death. In the 106 patients that were evaluated, 40 (38%) showed high 
periodontal disease and 27 (26%) had recurrent vascular events over a median of 24 months (range 
12–24 months). High periodontal disease patients had higher levels of interleukin-6 (p=0.01) and 
soluble intracellular adhesion molecule-1 (p=0.03). High periodontal disease was associated with 
recurrent vascular events before (Log rank p=0.01, hazard ratio 2.6, 95% CI, 1.2–5.7) and after 
adjustment for significant confounders -age and stroke status (Hazard Ratio 2.5, 95% confidence 
interval, 1.1 to 5.5, p=0.03); adjustment for possible confounders age, males, years of education 
and cardioembolic strokes (hazard ratio 2.8, 95% confidence interval, 1.2–6.5, p=0.02); and 
adjustment for propensity score that accounted for all potential measured confounders (hazard 
ratio 2.8, 95% confidence interval,1.2–6.5, p=0.02). There is an independent association between 
high periodontal disease and recurrent vascular events in stroke/TIA patients. High periodontal 
disease is also associated with higher serum levels of interleukin-6 and soluble intracellular 
adhesion molecule-1.
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Periodontal disease (PD) is present in approximately 40% of the adult population in the 
United States.1 Post-hoc analyses of prospective-longitudinal studies and smaller case-
control studies have reported an association between PD and incident stroke.2 These studies 
show that PD appears to bear a stronger association with stroke than coronary artery disease 
(CAD).3 In a combined analysis of two prospective studies, PD was found to increase the 
risk of incident stroke nearly three-fold.4 Recently, a case control study confirmed the 
independent graded association between the severity of PD and the risk of incident stroke.5 
In the present study, we investigated the effect of high periodontal disease (HPD) on 
recurrent vascular events in ischemic stroke/transient ischemic attack (TIA) patients. A 
recent prospective study found an association between inflammatory markers, with recurrent 
vascular events in stroke/TIA patients.6 PD has been postulated to be a result of a complex 
interplay of infection, immune and resulting inflammatory response.7 A growing body of 
evidence suggests that infections, and associated inflammatory markers may be emerging as 
potentially modifiable stroke risk factors.8 Therefore, the associations between PD and 
inflammatory markers with recurrent vascular events were investigated.
PATIENTS AND METHODS
In this prospective, longitudinal, hospital-based cohort study, consecutive patients admitted 
with stroke/TIA were screened for eligibility. All patients had risk factors assessed, and were 
classified into etiological stroke subtypes. A brain CT/MRI was used to detect cerebral 
ischemia as well as exclude intracerebral and subarachnoid hemorrhage. Other exclusion 
criteria included: age <18 years, coma, conditions limiting life expectancy to <12 months, 
having <5 teeth (PD assessment unreliable), recent infection and/or antibiotic use (within 30 
days). The study was approved by the local Institutional Review Board and a written 
informed consent was obtained prior to study participation. Enrolled patients underwent 
protocol-mandated assessments for PD, serum inflammatory markers and follow-up for 
recurrent vascular events.
PD Assessments
The dental examiners calibrated against a standard examiner, as well as each other for 
measures of PD. These dental examiners were not involved in medical chart review, 
consenting, clinical data collection and were intentionally uninformed as to the subject’s 
stroke information to avoid potential measurement bias. At the end of their examination, 
patients were advised in writing as to their periodontal status but were not referred for care 
to avoid follow-up bias. Specifically, the PD assessment included measurements of probing 
pocket depth and gingival recession on six sites for all teeth using a UNC-12 periodontal 
probe rounded to the next lower whole millimeter. Attachment level (AL), which is a valid 
measure of historical periodontal destruction,9 was calculated from the sum of pocket depth 
and gingival recession scores. Extent of PD was derived from percentage of sites with AL ≥ 
5 mm. Corrections were made to adjust for the fact that buccal sites often exhibit AL that 
consists primarily of gingival recession from causes not related to periodontitis.10 Based on 
the extent of AL ≥ 5 mm, subjects were divided into those with low periodontal disease 
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(LPD) (lower two tertiles with extent of attachment loss <1.3%) and those with HPD 
(highest tertile with extent of AL ≥ 1.3%). Our previous work has indicated that mild 
periodontitis is unlikely to have any systemic effects or influence on clinical outcome; 
further, our previous research has indicated evidence that more extensive infection is needed 
for periodontitis to affect vascular risk.10 It is important to have a referent group with little 
or no periodontal disease, rather than comparing the “cases” to a group that included 
individuals with moderate levels of disease. Stroke/TIA predominantly affects older 
population (50 years and older), in whom an estimated third have severe periodontitis.11 
Based on this consideration we selected a priori, the cutoff using highest tertile, to capture 
the severe periodontitis subjects and yet also provide adequate sample size in each cell. To 
investigate the measure, correlations between extent of AL ≥ 5 mm and other measures of 
PD12 (mean pocket depth, extent pocket depth ≥ 4mm, mean attachment loss, extent 
attachment loss ≥ 3 mm, extent plaque score ≥ 1, extent gingival index ≥1 and extent 
bleeding on probing) were assessed and showed good distinction of the groups in terms of 
association with the outcome.
Clinical Definitions
Stroke and stroke risk factors were defined based on previously described criteria.13 Stroke 
risk factors, laboratory assessments and stroke subtype were assessed at the time of initial 
qualifying event (stroke/TIA). TIA was defined as brief episodes of neurological dysfunction 
resulting from focal cerebral ischemia not associated with permanent cerebral infarction.14 
Myocardial Infarction (MI) was defined according to criteria modified from the 2000 
Consensus Conference of the European and American Colleges of Cardiology.15 Vascular 
death was defined as death ≤ 30 days from stroke/MI, where other causes of death had been 
excluded, or a sudden death from unexplained cause(s).
Laboratory measurements
From samples taken at enrollment, patients were assessed for the following inflammatory 
markers: serum interleukin-6 (IL-6), high sensitivity C-reactive protein (hs-CRP) and 
soluble intracellular adhesion molecule-1 (s-ICAM). Serum levels of s-ICAM and IL-6 were 
determined using commercial ELISA assay kits, and hs-CRP was determined with FMAP 
multiplex assay on a BioPlex 200 system. Reagents for assays were from R&D Systems 
(Minneapolis, MN). Patients receiving antibiotics for infection at the time of enrollment 
were excluded (N=1). Other causes of inflammation or chronic inflammatory disease were 
ruled out by screening the Atherosclerosis Risk in Communities (ARIC) inflammation form, 
administered at enrollment.16
Assessment of Stroke Etiology, Stroke Severity and TIA symptoms
Ischemic stroke etiology was classified using the Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) criteria.17 The initial ischemic stroke severity was measured using the 
National Institutes of Health Stroke Scale (NIHSS) performed on presentation to the hospital 
by qualified personnel. All TIAs were assessed by diffusion weighted image to rule out 
ischemic stroke.18 Additionally, in patients in whom the diagnosis of TIA was related to 
cerebral ischemia, ABCD2 score was assessed to determine if the patients were likely to be 
experiencing a true TIA.19
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Follow-up phone calls were conducted at 6-month intervals for a median of 24 months from 
enrollment for vascular events including stroke, MI and death. During follow-up phone-
calls, patients were asked about hospitalization occurring, occurrence of MI or recurrent 
stroke/TIA. For patients with outcome events, the clinical records were reviewed for 
confirmation. Date and cause of death were recorded for patients who died during the study. 
The recurrent vascular event was adjudicated by investigators, who were blinded to the PD 
status.
Statistical analysis
Statistical analysis was performed using SAS version 9.2 (SAS institute, Cary, NC) and 
Stata version 12.0 (Stata Corporation, College Station, TX). All normally distributed 
continuous variables are reported as mean ± standard deviation and compared using t-tests. 
Non-normally distributed continuous variables are depicted as median (inter-quartile range) 
and compared using Mann-Whitney U-test. All categorical variables are reported as 
proportions and inter-group difference was assessed by the χ2 test. Initially, the cumulative 
event-free rates for the time to composite vascular events (stroke, TIA, MI and vascular 
death) were estimated by Kaplan-Meier product limit method and the two groups, those with 
HPD and those with LPD, compared by the log-rank test. Subsequently, Cox proportional 
hazards analysis was used to identify risk factors for composite vascular events after 
adjusting for significant confounders using methods discussed below. Complete exposure 
(periodontal status) and outcome (recurrent vascular event) was available in all 106 enrolled 
subjects. Missing data in the laboratory parameters (4%) were replaced with the mean for 
the cohort for univariate and multivariable analyses.
Covariates assessed for confounding included stroke risk factors, laboratory parameters 
known to be associated with stroke risk (low-density lipoprotein [LDL], high-density 
lipoprotein [HDL] and homocysteine levels), and stroke subtypes. The covariates assessed 
for confounding also included those that were found to confound the association between 
PD and stroke in prior studies2–4 and included age, gender, race, hypertension, diabetes, 
hypercholesterolemia, body mass index (BMI), CAD, smoking, alcohol use, education level 
and estimated annual income. Only the covariates that were noted to change the hazards 
ratio (HR) by ≥ 5% were considered to produce significant confounding and included in 
Model 1. In Model 2, the covariates included were baseline characteristics that were 
significantly different (<0.05) among exposure groups. The results in each of these models 
were expressed as adjusted HRs and corresponding 95% confidence interval (CI). Propensity 
scores were calculated for each study subject by applying the subject’s values to the logistic 
model.20 The propensity score reflected each subject’s conditional probability of being 
exposed (HPD) given the confounding variables. The c-statistic for the propensity score 
model was 0.76, indicating an acceptable discrimination between HPD and LPD groups. The 
results in each of these models were expressed as adjusted HRs and corresponding 95% CI.
Sample size estimation was based on assumption that stroke/TIA patients have a high rate of 
composite vascular event as noted in prior studies.21, 22 With a total sample size of 100 and 
at least 40 participants in each exposure group, we estimated we would have a 90% power to 
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detect a 15% difference in composite vascular event (a priori hypothesis) by log-rank test. 
The two-tailed Type I error rate (alpha) was set at 0.05.
Our data did not include a measure of medical therapy compliance. Non-compliance is 
associated with PD and also associated with recurrent strokes. An obvious concern is that 
therapy non-compliance could fully mediate the established effects of PD. As such, we 
assessed the sensitivity of the HPD results in fitted survival models to the unmeasured 
confounder of medical noncompliance.23
RESULTS
Of the 156 patients that were screened, 110 met all the selection criteria and consented to the 
study; 106 patients completed a full periodontal examination (mean ± standard deviation = 
29±13 days, from index stroke/TIA). The various measures of PD showed significant 
correlation with the one used to define HPD –highest tertile of subjects with extent of AL ≥ 
5 mm (Table 1). Baseline characteristics of the study patients stratified into HPD (N=40) and 
LPD (N=66) are described in Table 2. Patients with HPD were more likely to be older 
(p=0.05), males (p=0.03) and have fewer years of education (p=0.007). Stroke patients were 
more likely to have HPD than TIA patients (42% vs. 25%) although the difference did not 
reach statistical significance (p=0.11). The proportions of the stroke subtypes appear to be 
different between HPD and LPD (p=0.03). Specifically, patients with HPD were more likely 
to have cardioembolic strokes (28% vs. 6%, p=0.02). Although, large artery 
atherothrombosis was less common in the LPD, the intergroup difference was not 
statistically significant. In the subset of patients with stroke (N=78) median NIHSS was 
higher in the HPD group (5) compared to the LPD group (3), although the difference did not 
reach statistical significance (p=0.07). In the remaining subset of TIA patients (N=28), the 
median ABCD2 score was higher (p=0.03) in the HPD group (4) compared to the LPD 
group (3).
The laboratory characteristics including inflammatory markers are outlined in Table 3. There 
were no significant differences between the HPD and LPD groups in fasting lipid profiles. 
Mean LDL was greater than 100 mg/dl across both groups, which is the target LDL for 
secondary stroke prevention.1 Plasma homocysteine level, although higher in HPD 
compared to LPD, was not significantly different (p=0.26). Among the inflammatory 
markers, IL-6 levels (p=0.01) and s-ICAM levels (p=0.04) were significantly higher in the 
HPD compared to LPD. There were no significant differences between HPD and the LPD in 
the level of hs-CRP which was elevated for both groups.
Over a median of 24 months from enrollment, 27 patients exhibited vascular events; 
including, sixteen with cerebrovascular events (9 stroke and 7 TIAs), three MIs, and eight 
vascular deaths. Sixteen (40%) of the 40 patients with HPD had vascular events; including, 
nine with cerebrovascular events (5 strokes and 4 TIAs), two MIs and five vascular deaths. 
Among the 66 patients with LPD, 11 (17%) had vascular events, including seven stroke/TIA, 
one MI and three vascular deaths over the same period of follow-up. There was a significant 
difference in cumulative event-free survival between the HPD group (mean survival 2.1 
years, 95% CI 1.6–2.5 years) and LPD group (mean survival 2.7 year, 95% CI 2.4–2.9 
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years). The two distributions were significantly different according to log-rank testing 
(p=0.01) and are depicted in the Kaplan-Meier survival curve (Figure 1). Among all the 
covariates, only age and stroke status significantly confounded the PD and composite 
vascular outcome association. After adjustment for these confounders, association between 
PD and composite vascular events, remained significant (HR 2.5, 95% CI, 1.1 to 5.5, 
p=0.03, Table 4). As noted above, stroke/TIA patients with HPD were older, had higher 
proportion of males, fewer years of education and higher rates of cardioembolic strokes 
(Table 2). After adjustment for these covariates, association between PD and composite 
vascular events, remained significant (HR 2.8, 95% CI, 1.2 to 6.5, p=0.02, Table 4). 
Multivariable Cox regression showed HPD was also associated with composite vascular 
events, after adjustment for propensity score (HR 2.8, 95% CI 1.2 – 6.5, p = 0.02, Table 4).
The sensitivity of the HPD results in fitted survival models to the unmeasured confounder of 
medical noncompliance is shown in Table 5.23 To fully mediate the association of HPD, 
medication non-compliance must have a hazard ratio of at least 1.3 where noncompliance 
was 1.75 times as likely (70%/40%) among the HPD patient.
DISCUSSION
Our findings indicate that in stroke/TIA patients, HPD is independently associated with an 
increased risk of recurrent vascular events. The Kaplan-Meier plots (Figure 1) suggest 
significant separation of survival curves in the HPD and LPD patient groups, at and beyond 
six months from the periodontal assessment.
To our knowledge, we are one of the first to report an association between PD and recurrent 
vascular events in a stroke/TIA population. In the past, at least four case-control and three 
cohort studies have reported a major positive association between PD and ischemic stroke, in 
stroke-free populations24 with similar reported effect size. The mechanisms by which 
periodontitis may contribute to ischemic stroke have recently been reviewed.25 The proposed 
mechanisms include inflammation-mediated procoagulant state, atherosclerosis mediated by 
direct microbial invasion of blood vessel wall as well as systemic inflammatory markers, and 
interaction with vascular risk factors.
The association between PD and cardiovascular disease is well established;2 however, the 
link between PD and ischemic stroke has only recently been explored. A recent meta-
analysis did not find evidence to support a causal association between PD and stroke 
(ischemic and hemorrhagic strokes combined).26 Hemorrhagic stroke, however, is 
pathophysiologically distinct from ischemic stroke in the fact that it is unrelated to 
atherosclerosis. Eliminating the studies that included hemorrhagic strokes, there are two 
cohorts, two case-controls and one cross sectional study(s) that have specifically looked at 
ischemic stroke as the sole dependent variable.25 All of these studies show significant 
association between PD and ischemic stroke. The most powerful evidence, in humans, for a 
mechanism which links PD with ischemic stroke is the isolation of dental pathogenic 
bacteria within carotid plaque27 and the association between serological markers of dental 
pathogen with carotid intimal medial thickness.10 A recent case-control study found an 
association between the antibody to Porphyromonas gingivalis, with carotid atherosclerosis 
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and atrial fibrillation.28 Since atrial fibrillation is a common reason for cardioembolic stroke, 
our results which found a significant association between HPD and cardioembolic stroke, is 
not surprising (Table 1).
We found a significant association between HPD and levels of serum inflammatory markers, 
namely IL-6 and s-ICAM. The nidus that leads to a downstream increase in s-ICAM is IL-6. 
Further, IL-6 is also a potent inducer of CRP release which has been suggested to directly 
alter vascular integrity; thus, promoting atherogenesis.29 We, however, also found 
consistently high hs-CRP values across both groups with no statistical difference. This 
finding may be explained by the fact that both HPD and LPD groups included stroke/TIA 
subjects with high prevalence of stroke risk factors. As noted by others, this finding is also 
consistent with the hypothesis that the association between CRP levels and stroke can be 
explained by the patient’s age and risk factors.30
Finally, our results show study participants whom had less years of education were more 
likely to have HPD. This finding is consistent with a recent case-control study that found 
education was an important contributor to the stroke risk associated with lower 
socioeconomic status.31 Further, two meta-analyses, have shown that patients with low 
educational attainment are at a greater risk of developing PD32 and stroke; regardless, of 
traditional risk factors.33 Less education, may contribute to poor care and compliance of 
stroke risk factors and dental care.
This study has a few limitations. First, generalisability may be limited by the requirement 
that stroke/TIA patients agreeing to have PD assessments. Second, the sample size of the 
study, although powered to test the primary hypothesis, is inadequate to test the association 
within subgroups such as TIA or the individual stroke subtypes. Third, elevated hs-CRP 
could have been attributable to another underlying infectious process; however, this 
possibility is unlikely as all participants were screened for recent antibiotic use or illness. 
Furthermore, intensive periodontal therapy has been shown to improve patients' vascular risk 
factor profile.34 In a randomized study involving severe periodontitis patients, intensive 
periodontal therapy led to an improvement in endothelial function, hinting that aspects of 
periodontitis-associated inflammation and vascular injury might be reversible.35 Results of a 
recently published population-based study in Taiwan suggests that maintenance of 
periodontal health by dental prophylaxis and PD treatment can help reduce the incidence of 
ischemic stroke.36, 37 Further studies are needed to assess whether PD treatment can lead to 
reduction in serum inflammatory markers and prevent recurrent vascular events in 
stroke/TIA patients. Finally, we did not measure medical therapy non-compliance, known to 
adversely impacts outcomes in stroke/TIA patients.38
To address the issue of medical therapy non-compliance, an unmeasured confounder, we 
conducted a sensitivity analysis to test its effect on the association between HPD and 
recurrent vascular events. To fully mediate the association of HPD, medication non-
compliance must have a hazard ratio of at least 1.3 where noncompliance was 1.75 times as 
likely (70%/40%) among the HPD patient. Based on reported rate of non-compliance of 
approximately a third of stroke/TIA patients,38 this scenario is less likely.
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Internal validity of the model was tested by taking repeated bootstrap samples (with 
replacement) from the original data, models are estimated using a backward stepwise 
procedure.39 The final list of predictors is comprised of those predictors which were retained 
in a high proportion of the models (> 60%). A future study is needed to test external validity.
In conclusion, we found that PD is associated with recurrent vascular events in stroke/TIA 
patients. We also found an association between PD and inflammatory markers, namely IL-6 
and s-ICAM. Further studies are needed to examine if treatment of HPD can result in lower 
levels of inflammatory markers and a lower rate of recurrent vascular events in stroke/TIA 
patients.
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Kaplan-Meier Survival Functions: Differences for Stroke/TIA Patients with Low versus 
High Periodontal Disease.
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Table 1
The correlation of various measures of periodontal disease with the upper quartile of extent of attachment loss 
≥5 mm.






Mean Pocket Depth 2.41 (0.62) 1.92 (0.35) <0.0001
Extent Pocket Depth ≥4mm 15.7 (14.5) 4.93 (6.55) <0.0001
Mean Attachment Loss (Interproximal) 2.48 (0.98) 1.30 (0.38) <0.0001
Extent Attachment Loss ≥3 mm (Interproximal) 41.8 (19.4) 8.31 (9.03) <0.0001
Extent Plaque Score ≥1 85.6 (19.4) 70.1 (28.0) 0.001
Extent Gingival Index ≥1 94.5 (10.9) 88.1 (18.6) 0.03
Extent Bleeding On Probing 43.0 (28.2) 31.5 (20.7) 0.03
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Table 2
Baseline clinical characteristics of stroke/TIA patients with low and high periodontal disease. Proportions are 






Age * 61 ± 12 56 ± 16 0.05
Male Gender 68%† 45% 0.03
Non-Caucasian Race 38% 23% 0.10
Hypertension 70% 68% 0.84
Diabetes 25% 15% 0.21
Hypercholesterolemia 75% 64% 0.22
Coronary Artery Disease (CAD) 15% 9% 0.35
Atrial Fibrillation 15% 11% 0.50
Body Mass Index (BMI)* 29.6 ± 7.6 28.6 ± 4.4 0.43
Ever Smoker 58% 53% 0.65








5 (3, 7) 3 (2, 5) 0.07
TOAST classification
Large artery atherothrombosis 13% 8%
Cardioembolism 28% 6%
Small vessel occlusive disease 8% 12% 0.03†
Others
(Known, Unknown and ≥ 2 causes)
35% 42%
TIA 18% 32% 0.11
ABCD2**
(TIA patients only)
4 (4, 5) 3 (3, 4) 0.09
*
Normally distributed continuous values are depicted as mean ± standard deviation and compared using t-test
**
Continuous variables that are not normally distributed are depicted as median (inter-quartile range) and compared using Mann-Whitney U-test
†
2×6 contingency table χ2 test
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Table 3
Laboratory characteristics of stroke/TIA patients with low and high periodontal disease.







Total Cholesterol (mg/dl)* 181 ± 47 185 ± 48 0.74
LDL Cholesterol (mg/dl)* 106 ± 43 107 ± 43 0.90
HDL Cholesterol (mg/dl)* 51 ± 19 52 ± 17 0.66
Triglycerides (mg/dl)** 120 (95,167) 118 (75–165) 0.93
Homocysteine (mcg/dl)** 10.3 (7.3,12.9) 8.3 (6.2,10.7) 0.26
hs-CRP (mg/L)** 3.1 (1.3–5.9) 3.5 (1.1–6.1) 0.68
IL-6 (pg/ml)** 5.0 (2.8–8.4) 2.9 (1.8–4.5) 0.01
s-ICAM (pg/ml)* 377 ± 180 307 ± 123 0.04
*
Normally distributed continuous values are summarized as mean ± standard deviation and compared using t-test
**
Continuous variables that are not normally dist ributed are summarized as median (inter-quartile range) and compared using Mann-Whitney U-
test
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Table 4
High periodontal disease: Hazards ratio for recurrent vascular events in stroke/TIA patients.
Unadjusted (Crude) 2.6 (1.2–5.7)
Adjusted (Model 1)* 2.5 (1.1–5.5)
Adjusted (Model 2)** 2.8 (1.2–6.5)
Adjusted (Model 3)*** 2.8 (1.2–6.5)
*
Adjusted for age and stroke status
**
Adjusted for age, gender, education and cardioembolic stroke subtype
***
Adjusted for Age, Gender, Race, Hypertension, Diabetes, Hypercholesterolemia, BMI, coronary artery disease, Smoking, Excessive Alcohol 
Use, Education level and Annual Income are combined into a single propensity score.
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